Risk-Based Decisions Topic of Panel Talk at Quality Consortium

DURHAM, N.C., June 7, 2017 — Premier Research’s leading quality expert will host a panel discussion on risk-based decision-making at the Avoca Quality Consortium’s 2017 summit in Dublin.

The discussion, starting at 2:15 p.m. June 8, will address needs in transforming human capital management and improving risk mitigation in clinical trial execution. It’s an ideal complement to the summit’s focus on the changing landscape of clinical research.

Ms. Dodsworth, Vice President of Global Quality Assurance at Premier Research, has more than 25 years of experience in quality assurance. A Chartered Scientist, she co-chairs the Institute of Clinical Research’s Good Clinical Practices Forum.

About Premier Research

Premier Research is a leading clinical development service provider that helps highly innovative biotech and specialty pharma companies transform breakthrough ideas into reality. The company has a wealth of experience in the execution of global, regional and local clinical development programs with a special focus on addressing unmet needs in areas such as analgesia, dermatology, medical device, neuroscience, oncology, pediatric, and rare disease. Premier Research operates in 84 countries and employs 1,000 professionals, including a strong international network of clinical monitors and project managers, regulatory, data management, statistical, scientific, and medical experts. They are focused on smart study design for advanced medicines that allow life-changing treatments.

Author Details

Anna Barham
Phone Us Now
Email Us Now